AccuraGen
PrivateLast Round
Series B
Jun 1, 2016
Total Funding Raised
$46.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AccuraGen is a biotechnology company that develops liquid biopsy technology for personalized cancer treatment and disease monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccuraGen Comparables
Compare AccuraGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Predicine | 84% | |
| Quest Diagnostics | 79% | |
| Personalis Inc | 78% | |
AccuraGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 1, 2016 | ||||
| Series A | Feb 6, 2015 |
AccuraGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series B |
| StartX | Series B |
| Junson Capital | Series B |
| 德同资本 | Series B |
| DT Capital Limited | Series B |
| Nan Fung Group (Investment Arm) | Series B |
| Decheng Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 22, 2x the trailing average.
- Jun 1, 2016
$40M round with participation from Temasek and Nan Fung Group.
AccuraGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AccuraGen's valuation, stock price, and market status.